🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the manufacturers of acetaminophen, asserting the firms withheld potential risks that the pain reliever presented to children's brain development.

The lawsuit arrives a month after Donald Trump publicized an unsubstantiated connection between consuming acetaminophen - alternatively called paracetamol - throughout gestation and autism spectrum disorder in young ones.

Paxton is filing suit against J&J, which formerly manufactured the drug, the only pain reliever approved for expectant mothers, and Kenvue, which presently makes it.

In a statement, he said they "misled consumers by profiting off of discomfort and marketing drugs ignoring the dangers."

The manufacturer states there is insufficient reliable data connecting Tylenol to autism spectrum disorder.

"These manufacturers deceived for years, deliberately risking countless individuals to increase profits," the attorney general, from the Republican party, stated.

The manufacturer commented that it was "very worried by the dissemination of inaccurate information on the security of acetaminophen and the likely effects that could have on the welfare of women and children in America."

On its official site, Kenvue also said it had "continuously evaluated the applicable studies and there is insufficient valid information that indicates a established connection between using acetaminophen and autism."

Organizations representing medical professionals and healthcare providers concur.

ACOG has said acetaminophen - the primary component in Tylenol - is a restricted selection for pregnant women to treat pain and elevated temperature, which can pose serious health risks if not addressed.

"In more than two decades of research on the utilization of paracetamol in gestation, zero credible investigations has definitively established that the use of paracetamol in any period of gestation leads to neurodevelopmental disorders in young ones," the organization said.

The court filing mentions current declarations from the former administration in claiming the drug is reportedly hazardous.

Recently, the former president raised alarms from health experts when he instructed pregnant women to "resist strongly" not to take Tylenol when sick.

The FDA then released a statement that medical professionals should think about restricting the consumption of Tylenol, while also declaring that "a direct connection" between the drug and autism in young ones has not been established.

Health Secretary Robert F Kennedy Jr, who manages the FDA, had vowed in April to undertake "extensive scientific investigation" that would establish the source of autism in a limited time.

But specialists cautioned that discovering a unique factor of autism - thought by researchers to be the outcome of a complicated interplay of genetic and external influences - would be difficult.

Autism is a type of permanent neurological difference and condition that influences how persons encounter and relate to the surroundings, and is identified using physician assessments.

In his court filing, the attorney general - a Trump ally who is seeking US Senate - alleges the manufacturer and Johnson & Johnson "intentionally overlooked and tried to quiet the science" around acetaminophen and autism.

The lawsuit aims to force the corporations "remove any commercial messaging" that asserts Tylenol is safe for expectant mothers.

The Texas lawsuit mirrors the concerns of a group of guardians of minors with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the makers of acetaminophen in two years ago.

A federal judge threw out the lawsuit, stating studies from the family's specialists was inconclusive.